Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00876395 · COMPLETED
Trial details
- NCT number
- NCT00876395
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-10
- Primary completion
- 2014-05-30
- Enrollment
- 719
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.